
Aimed Alliance Shares Concerns Regarding Affordability Review Process with Oregon PDAB
Aimed Alliance submitted a comment to the Oregon Prescription Drug Affordability Board (PDAB) urging it…
Aimed Alliance submitted a comment to the Oregon Prescription Drug Affordability Board (PDAB) urging it…
Aimed Alliance sent a letter to Colorado Representative Ken DeGraaf’s regarding his special session bill …
Aimed Alliance has published a new resource highlighting pharmacy benefit manager (PBMs) practices and proposed…
Following a May court ruling that pharmaceutical manufacturers must receive Health Resources and Services Administration…
Beginning in January 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the…
On July 28, Aimed Alliance sent a letter to the Centers for Consumer Information and…
Prior to the Maryland Prescription Drug Affordability Board’s July meeting to conduct cost affordability reviews…
On July 4, 2025, President Trump signed the One Big Beautiful Bill Act into law,…
Washington, D.C. — June 30, 2025 — The not-for-profit Aimed Alliance, released a comprehensive new…
On June 26, 2025, Aimed Alliance submitted a comment to the Centers for Medicare &…